icn pharmaceut inc has about 500 mln dlrs cash and anoth billion dlrs avail credit which intend buy pharmaceut compani chairman milan panic said compani annual meet said acquisit could next month compani has near two billion dlrs avail for acquisit today panic said ad investig number compani compani be studi could possibl acquir friend basi said panic also said intend seek board approv today repurchas three mln icn common share discuss possibl acquisit panic said such purchas necessari becaus icn current market capabl would not suffici support distribut compani product given icn expect for market growth worldwid icn princip product ribavirin also known virazol drug market number countri and describ broad base anti viral compani has said it possibl applic includ treatment some type hepat herp influenza childhood diseas and hemorrhag fever icn has been focus consir investor attent recent month becaus virazol which has undergon clinic trial possibl treatment some aid relat diseas panic said today would not discuss drug with aid until food and drug administr complet it review data submit compani said investig drug be conduct hous subcommitte continu subcommitte and fda have acknowledg conduct separ investig determin whether not icn witheld data from fda advers reaction drug virazol approv for market aerosol form treatment for infect strike infant call respiratori syncyti virus reuter 